Pravastatin inhibits fibrinogen‑ and FDP‑induced inflammatory response via reducing the production of IL‑6, TNF‑α and iNOS in vascular smooth muscle cells

Lu,Peipei; Liu,Juntian; Pang,Xiaoming

doi:10.3892/mmr.2015.4149

Pravastatin inhibits fibrinogen‑ and FDP‑induced inflammatory response via reducing the production of IL‑6, TNF‑α and iNOS in vascular smooth muscle cells

Authors:
- Peipei Lu
- Juntian Liu
- Xiaoming Pang
View Affiliations

Affiliations: Department of Pharmacology, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi 710061, P.R. China
Published online on: July 29, 2015 https://doi.org/10.3892/mmr.2015.4149
Pages: 6145-6151

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atherosclerosis is a chronic inflammatory response of the arterial wall to pro‑atherosclerotic factors. As an inflammatory marker, fibrinogen directly participates in the pathogenesis of atherosclerosis. Our previous study demonstrated that fibrinogen and fibrin degradation products (FDP) produce a pro‑inflammatory effect on vascular smooth muscle cells (VSMCs) through inducing the production of interleukin‑6 (IL‑6), tumor necrosis factor‑α (TNF‑α) and inducible nitric oxide synthase (iNOS). In the present study, the effects of pravastatin on fibrinogen‑ and FDP‑induced expression of IL‑6, TNF‑α and iNOS were observed in VSMCs. The results showed that pravastatin dose‑dependently inhibited fibrinogen‑ and FDP‑stimulated expression of IL‑6, TNF‑α and iNOS in VSMCs at the mRNA and protein level. The maximal inhibition of protein expression of IL‑6, TNF‑α and iNOS was 46.9, 42.7 and 49.2% in fibrinogen‑stimulated VSMCs, and 50.2, 49.8 and 53.6% in FDP‑stimulated VSMCs, respectively. This suggests that pravastatin has the ability to relieve vascular inflammation via inhibiting the generation of IL‑6, TNF‑α and iNOS. The results of the present study may aid in further explaining the beneficial effects of pravastatin on atherosclerosis and related cardiovascular diseases. In addition, they suggest that application of pravastatin may be beneficial for prevention of atherosclerosis formation in hyperfibrinogenemia.

View Figures

View References

1	Hansson GK: Inflammation, atherosclerosis and coronary artery disease. N Engl J Med. 352:1685–1695. 2005. View Article : Google Scholar : PubMed/NCBI
2	Libby P: Inflammation in atherosclerosis. Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
3	Bermudez EA, Rifai N, Buring J, Manson JE and Ridker PM: Interrelationships among circulating interleukin-6, C-reactive protein and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 22:1668–1673. 2002. View Article : Google Scholar : PubMed/NCBI
4	Lind L: Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 169:203–214. 2003. View Article : Google Scholar : PubMed/NCBI
5	Huber SA, Sakkinen P, Conze D, Hardin N and Tracy R: Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 19:2364–2367. 1999. View Article : Google Scholar : PubMed/NCBI
6	Ross R: Atherosclerosisan inflammatory disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
7	Lominadze D, Dean WL, Tyagi SC and Roberts AM: Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol (Oxf). 198:1–13. 2010. View Article : Google Scholar
8	Sen U, Tyagi N, Patibandla PK, Dean WL, Tyagi SC, Roberts AM and Lominadze D: Fibrinogen-induced endothelin-1 production from endothelial cells. Am J Physiol Cell Physiol. 296:C840–C847. 2009. View Article : Google Scholar : PubMed/NCBI
9	Szaba FM and Smiley ST: Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood. 99:1053–1059. 2002. View Article : Google Scholar : PubMed/NCBI
10	Robson SC, Shephard EG and Kirsch RE: Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-lbeta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol. 86:322–326. 1994. View Article : Google Scholar : PubMed/NCBI
11	Kuhns DB, Nelson EL, Alvord WG and Gallin JI: Fibrinogen induces IL-8 synthesis in human neutrophils stimulated with formyl-methionyl-leucyl-phenylalanine or leukotriene B(4). J Immunol. 167:2869–2878. 2001. View Article : Google Scholar : PubMed/NCBI
12	Tsakadze NL, Zhao Z and D'Souza SE: Interaction of inter-cellular adhesion molecule-1 with fibrinogen. Trends Cardiovasc Med. 12:101–108. 2002. View Article : Google Scholar : PubMed/NCBI
13	Mosesson MW: Fibrinogen and fibrin structure and functions. J Thromb Haemost. 3:1894–1904. 2005. View Article : Google Scholar : PubMed/NCBI
14	Tyagi N, Roberts AM, Dean WL, Tyagi SC and Lominadze D: Fibrinogen induces endothelial cell permeability. Mol Cell Biochem. 307:13–22. 2008. View Article : Google Scholar
15	Patibandla PK, Tyagi N, Dean WL, Tyagi SC, Roberts AM and Lominadze D: Fibrinogen induces alterations of endothelial cell tight junction proteins. J Cell Physiol. 221:195–203. 2009. View Article : Google Scholar : PubMed/NCBI
16	Rauch BH, Müschenborn B, Braun M, Weber AA and Schrör K: ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cells. Eur J Pharmacol. 577:54–57. 2007. View Article : Google Scholar : PubMed/NCBI
17	Naito M, Stirk CM, Smith EB and Thompson WD: Smooth muscle cell outgrowth stimulated by fibrin degradation products: The potential role of fibrin fragment E in restenosis and atherogenesis. Thromb Res. 98:165–174. 2000. View Article : Google Scholar : PubMed/NCBI
18	Hicks RC, Golledge J, Mir-Hasseine R and Powell JT: Vasoactive effects of fibrinogen on saphenous vein. Nature. 379:818–820. 1996. View Article : Google Scholar : PubMed/NCBI
19	Guo F, Liu JT, Wang CJ, Liu N and Lu PP: Fibrinogen, fibrin and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: Pro-inflammatory effect on atherosclerosis. Biochem Biophy Res Commun. 390:942–946. 2009. View Article : Google Scholar
20	Lu PP, Liu JT, Liu N, Guo F, Ji YY and Pang X: Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS. Life Sci. 88:839–845. 2011. View Article : Google Scholar : PubMed/NCBI
21	Veillard NR and Mach F: Statins: The new aspirin? Cell Mol Life Sci. 59:1771–1786. 2002. View Article : Google Scholar
22	Gaugler MH, Vereycken-Holler V, Squiban C, Vandamme M, Vozenin-Brotons MC and Benderitter M: Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat Res. 163:479–487. 2005. View Article : Google Scholar : PubMed/NCBI
23	Hadrava V, Tremblay J and Hamet P: Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension. 13:589–597. 1989. View Article : Google Scholar : PubMed/NCBI
24	Takemoto M and Liao JK: Pleiotropic effects of 3-hydroxy-3-meth-ylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 21:1712–1719. 2001. View Article : Google Scholar : PubMed/NCBI
25	Tedgui A and Mallat Z: Cytokines in atherosclewrosis: Pathogenic and regulatory pathways. Physiol Rev. 86:515–581. 2006. View Article : Google Scholar : PubMed/NCBI
26	Yudkin JS, Kumari M, Humphries SE and Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis. 148:209–214. 2000. View Article : Google Scholar : PubMed/NCBI
27	Kosmala W, Przewlocka-Kosmala M and Mazurek W: Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction. Int J Cardiol. 101:449–456. 2005. View Article : Google Scholar : PubMed/NCBI
28	Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH and Polak JM: Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 75:77–85. 1996.PubMed/NCBI
29	Luoma JS, Strålin P, Marklund SL, Hiltunen TP, Särkioja T and Ylä-Herttuala S: Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 18:157–167. 1998. View Article : Google Scholar : PubMed/NCBI
30	Radomski MW and Salas E: Nitric oxide-biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis. 118(Suppl): S69–S80. 1995. View Article : Google Scholar
31	Smith EB, Thompson WD, Crosbie L and Stirk CM: Fibrinogen/fibrin in atherogenesis. Eur J Epidemiol. 8(Suppl 1): 83–87. 1992. View Article : Google Scholar : PubMed/NCBI
32	Perez RL and Roman J: Fibrin enhances the expression of IL-lbeta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol. 154:1879–1887. 1995.PubMed/NCBI
33	Lin R, Liu J, Peng N, Yang G, Gan W and Wang W: Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells. Biol Pharm Bull. 28:1630–1634. 2005. View Article : Google Scholar : PubMed/NCBI
34	Peng N, Liu JT, Gao DF, Lin R and Li R: Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis. Atherosclerosis. 193:292–298. 2007. View Article : Google Scholar
35	Wang C, Liu J, Guo F, Ji Y and Liu N: Endothelin-1 induces the expression of C-reactive protein in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 389:537–542. 2009. View Article : Google Scholar : PubMed/NCBI
36	Han C, Liu J, Liu X and Li M: Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells. Atherosclerosis. 212:206–212. 2010. View Article : Google Scholar : PubMed/NCBI
37	Li M, Liu J, Han C, Wang B, Pang X and Mao J: Angiotensin II induces the expression of c-reactive protein via MAPK-dependent signal pathway in U937 macrophages. Cell Physiol Biochem. 27:63–70. 2011.PubMed/NCBI